The Korean journal of internal medicine

The Korean Association of Internal Medicine (대한내과학회)
권호 표지
DOI QR코드

DOI QR Code

Realities of KRAS-mutated non-small cell lung cancer

  • Min, Young Joo (Division of Oncology, Department of Hematology and Oncology, Ulsan University Hospital)
  • Received : 2017.03.24
  • Accepted : 2017.04.25
  • Published : 2017.05.01
⟨ Previous Next ⟩

Abstract

Keywords

References

  1. Matikas A, Mistriotis D, Georgoulias V, Kotsakis A. Targeting KRAS mutated non-small cell lung cancer: a history of failures and a future of hope for a diverse entity. Crit Rev Oncol Hematol 2017;110:1-12. https://doi.org/10.1016/j.critrevonc.2016.12.005
  2. Park S, Kim JY, Lee SH, et al. KRAS G12C mutation as a poor prognostic marker of pemetrexed treatment in non-small cell lung cancer. Korean J Intern Med 2017;32:514-522. https://doi.org/10.3904/kjim.2015.299